lobbying_activities: 3007499

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
3007499 871782a6-6815-4cde-900b-2b803f940e38 Q2 AMERICAN ASSOCIATION FOR JUSTICE 4733 AMERICAN ASSOCIATION FOR JUSTICE 2023 second_quarter CSP Forced Arbitration Injustice Repeal Act (FAIR). Protecting the Employment Rights of Service Members Act (PERSA). Justice for Servicemembers Act. Fairness in Nursing Home Arbitration Act. Bill to prohibit forced arbitration in health insurance contracts. PFAS Accountability Act. Resource Management PFAS Liability Protection Act of 2023 STOP Fentanyl Overdoses Act Nursing Home Improvement and Accountability Act. National Defense Authorization Act, with specific regard to amendments on SCRA and USERRA forced arbitration, MCA claims, and cyber incident reporting. VALID Act of 2023 Food and Drug Amendments of 2022, with specific regard to provisions on cosmetics. National Defense Authorization Act, with specific regard to amendments on SCRA and USERRA forced arbitration. SPEAK OUT Act. REINS Act FDA Safety and Landmark Advancements Act. Consolidated Appropriations Act, 2023, with regard to cosmetics legislation. Updated Drug labeling for Patient Safety Act. Protecting Older Americans Act Ending Forced Arbitration of Race Discrimination Act of 2023 Updated Drug Labeling for Patient Safety Act Draft legislation on PFAS. Draft asbestos ban legislation. Draft cosmetics reform legislation. Draft dietary supplement legislation. General lobbying on ending the use of forced arbitration for consumers and workers. General lobbying with regard to forced arbitration in nursing homes. General lobbying on minimum nursing home staffing rates. General lobbying with regard to COVID-19 liability. General lobbying on e-cigarettes safety and regulation. General lobbying on the FDA proposal regarding the testing of talc for asbestos. General lobbying on FIFRA preemption. General lobbying on glyphosate safety. General lobbying on drug pricing. General Lobbying on Confluence Flooding Compensation S. 269: Protect America's Children from Toxic Pesticides Act Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE   135000 0 0 2023-07-17T15:03:53-04:00